how do glp-1 drugs work Receptor Agonists as Treatments for Type 2 Diabetes Mechanisms of action of GLP-1RA.
Description
Tresiba typically causes weight gain of 1 to 4 kg, which is the opposite of GLP-1 medications that produce significant weight loss
Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-B activation
Given the risk that obesity represents to public health and the difficulty of achieving and maintaining weight loss via lifestyle changes alone, there is a need for pharmacological approaches to aid weight loss in some individuals
The meals that trigger the most GLP-1 production combine fiber, protein, healthy fat, and volume
Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN- Production via Suppressing JAK-STAT Pathway
2012;303(7):E899-907
